 Patrick Hu
Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 23 | 2021 | 327 | 5.500 |
Why?
| | Caenorhabditis elegans Proteins | 14 | 2019 | 207 | 3.530 |
Why?
| | Longevity | 9 | 2015 | 178 | 1.950 |
Why?
| | Coronary Vasospasm | 7 | 2026 | 9 | 1.700 |
Why?
| | Forkhead Transcription Factors | 7 | 2015 | 209 | 1.220 |
Why?
| | Insulin | 7 | 2021 | 2516 | 1.190 |
Why?
| | Research Personnel | 8 | 2026 | 185 | 1.120 |
Why?
| | Gene Expression Regulation, Developmental | 9 | 2020 | 910 | 1.040 |
Why?
| | Career Choice | 7 | 2026 | 235 | 0.970 |
Why?
| | Mutagenesis | 3 | 2016 | 194 | 0.970 |
Why?
| | Physicians | 9 | 2026 | 956 | 0.870 |
Why?
| | Transcription Factors | 6 | 2013 | 1736 | 0.820 |
Why?
| | Biomedical Research | 8 | 2026 | 719 | 0.790 |
Why?
| | Mutation | 16 | 2017 | 4090 | 0.790 |
Why?
| | Starvation | 1 | 2020 | 23 | 0.650 |
Why?
| | Life Cycle Stages | 1 | 2020 | 37 | 0.650 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 209 | 0.630 |
Why?
| | Signal Transduction | 12 | 2021 | 5224 | 0.620 |
Why?
| | Receptors, Peptide | 1 | 2019 | 18 | 0.610 |
Why?
| | Ethylnitrosourea | 2 | 2016 | 13 | 0.600 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 221 | 0.550 |
Why?
| | Aging | 3 | 2020 | 1973 | 0.550 |
Why?
| | Arrhythmias, Cardiac | 2 | 2023 | 356 | 0.550 |
Why?
| | Internal Medicine | 3 | 2026 | 279 | 0.540 |
Why?
| | Membrane Glycoproteins | 1 | 2019 | 499 | 0.500 |
Why?
| | RNA Splice Sites | 1 | 2016 | 51 | 0.470 |
Why?
| | Genome, Helminth | 1 | 2015 | 5 | 0.470 |
Why?
| | Sensory Receptor Cells | 1 | 2017 | 98 | 0.470 |
Why?
| | Myocardial Infarction | 2 | 2020 | 1211 | 0.450 |
Why?
| | Introns | 1 | 2016 | 256 | 0.440 |
Why?
| | Environment | 1 | 2017 | 293 | 0.440 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.440 |
Why?
| | Cholestenes | 3 | 2014 | 5 | 0.440 |
Why?
| | Gene Rearrangement | 1 | 2015 | 156 | 0.430 |
Why?
| | Animals | 23 | 2021 | 38102 | 0.430 |
Why?
| | Lysine | 1 | 2017 | 305 | 0.420 |
Why?
| | Neuronal Plasticity | 1 | 2017 | 305 | 0.410 |
Why?
| | Microbiota | 1 | 2021 | 730 | 0.400 |
Why?
| | Dosage Compensation, Genetic | 1 | 2013 | 12 | 0.390 |
Why?
| | Steroids | 2 | 2014 | 160 | 0.390 |
Why?
| | Receptor, Insulin | 5 | 2013 | 93 | 0.380 |
Why?
| | Hormones | 1 | 2013 | 135 | 0.370 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2013 | 317 | 0.360 |
Why?
| | Embryonic Development | 1 | 2013 | 125 | 0.360 |
Why?
| | Granulosa Cell Tumor | 1 | 2011 | 6 | 0.350 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2011 | 20 | 0.350 |
Why?
| | Genome | 1 | 2014 | 305 | 0.350 |
Why?
| | Transcription, Genetic | 2 | 2015 | 1454 | 0.340 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2011 | 40 | 0.340 |
Why?
| | Histones | 1 | 2017 | 666 | 0.340 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2010 | 440 | 0.340 |
Why?
| | Coronary Vessels | 3 | 2023 | 246 | 0.330 |
Why?
| | Spasm | 2 | 2022 | 21 | 0.320 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2014 | 534 | 0.320 |
Why?
| | Genomics | 2 | 2015 | 830 | 0.320 |
Why?
| | Heart Failure | 2 | 2023 | 2326 | 0.320 |
Why?
| | Models, Biological | 7 | 2017 | 1764 | 0.320 |
Why?
| | beta Catenin | 1 | 2011 | 254 | 0.300 |
Why?
| | Genetic Variation | 1 | 2014 | 977 | 0.290 |
Why?
| | MAP Kinase Signaling System | 2 | 2022 | 308 | 0.270 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2014 | 627 | 0.260 |
Why?
| | Genes, Helminth | 4 | 2013 | 30 | 0.250 |
Why?
| | Recombinant Fusion Proteins | 3 | 2019 | 666 | 0.240 |
Why?
| | Carrier Proteins | 1 | 2010 | 729 | 0.240 |
Why?
| | Genetic Techniques | 1 | 2006 | 66 | 0.230 |
Why?
| | Education, Medical | 2 | 2020 | 276 | 0.230 |
Why?
| | Ovarian Neoplasms | 1 | 2011 | 596 | 0.220 |
Why?
| | Genes, X-Linked | 2 | 2017 | 21 | 0.220 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2006 | 167 | 0.220 |
Why?
| | Chromosome Mapping | 3 | 2016 | 507 | 0.220 |
Why?
| | Base Sequence | 3 | 2016 | 2171 | 0.210 |
Why?
| | Internship and Residency | 3 | 2024 | 1269 | 0.200 |
Why?
| | Larva | 3 | 2017 | 240 | 0.200 |
Why?
| | Career Mobility | 1 | 2024 | 68 | 0.200 |
Why?
| | Taiwan | 4 | 2026 | 48 | 0.190 |
Why?
| | Syndrome | 2 | 2023 | 381 | 0.190 |
Why?
| | Apoprotein(a) | 1 | 2022 | 8 | 0.180 |
Why?
| | Coronary Angiography | 2 | 2023 | 328 | 0.180 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2016 | 2181 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 562 | 0.170 |
Why?
| | Lipoprotein(a) | 1 | 2022 | 69 | 0.170 |
Why?
| | Macrophage Activation | 1 | 2022 | 181 | 0.160 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2020 | 24 | 0.160 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 444 | 0.160 |
Why?
| | Animals, Genetically Modified | 3 | 2013 | 247 | 0.160 |
Why?
| | Coronary Artery Disease | 2 | 2019 | 750 | 0.160 |
Why?
| | Interleukin-6 | 2 | 2022 | 780 | 0.150 |
Why?
| | Lysosomes | 1 | 2020 | 131 | 0.150 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 407 | 0.150 |
Why?
| | Protein Precursors | 1 | 2019 | 136 | 0.140 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2019 | 118 | 0.140 |
Why?
| | Phenotype | 3 | 2016 | 3170 | 0.140 |
Why?
| | Cytochrome P-450 Enzyme System | 2 | 2010 | 162 | 0.140 |
Why?
| | Education | 1 | 2018 | 105 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 2 | 2020 | 175 | 0.130 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2018 | 94 | 0.130 |
Why?
| | National Institutes of Health (U.S.) | 3 | 2024 | 148 | 0.130 |
Why?
| | Humans | 25 | 2026 | 145783 | 0.130 |
Why?
| | Stents | 2 | 2020 | 564 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 917 | 0.130 |
Why?
| | Alleles | 2 | 2011 | 896 | 0.120 |
Why?
| | Electrocardiography | 1 | 2020 | 668 | 0.120 |
Why?
| | Nucleotide Motifs | 1 | 2016 | 36 | 0.120 |
Why?
| | Chromosome Breakpoints | 1 | 2015 | 9 | 0.120 |
Why?
| | Depressive Disorder | 1 | 2019 | 374 | 0.120 |
Why?
| | RNA Splicing Factors | 1 | 2016 | 66 | 0.120 |
Why?
| | X Chromosome | 1 | 2015 | 66 | 0.110 |
Why?
| | Sequence Deletion | 1 | 2016 | 191 | 0.110 |
Why?
| | Receptors, Somatomedin | 1 | 2015 | 5 | 0.110 |
Why?
| | Anxiety Disorders | 1 | 2019 | 371 | 0.110 |
Why?
| | Male | 13 | 2026 | 73011 | 0.110 |
Why?
| | Gene Dosage | 1 | 2015 | 145 | 0.110 |
Why?
| | Monocytes | 1 | 2018 | 539 | 0.110 |
Why?
| | Propensity Score | 3 | 2024 | 377 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2883 | 0.110 |
Why?
| | Ligands | 2 | 2014 | 668 | 0.100 |
Why?
| | Female | 13 | 2026 | 79045 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 900 | 0.100 |
Why?
| | Tyrosine Transaminase | 1 | 2013 | 4 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2015 | 399 | 0.100 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 558 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 217 | 0.100 |
Why?
| | Germ Cells | 1 | 2013 | 66 | 0.090 |
Why?
| | Mentors | 2 | 2026 | 217 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 778 | 0.090 |
Why?
| | RNA Interference | 2 | 2013 | 475 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2602 | 0.090 |
Why?
| | Genes, Dominant | 1 | 2011 | 100 | 0.090 |
Why?
| | Loss of Heterozygosity | 1 | 2011 | 52 | 0.090 |
Why?
| | Codon | 1 | 2011 | 92 | 0.090 |
Why?
| | Transgenes | 2 | 2010 | 190 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2017 | 789 | 0.080 |
Why?
| | Renal Artery Obstruction | 1 | 2011 | 30 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2018 | 1360 | 0.080 |
Why?
| | Middle Aged | 8 | 2026 | 36309 | 0.080 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 2010 | 8 | 0.080 |
Why?
| | Oxygenases | 1 | 2010 | 10 | 0.080 |
Why?
| | Awards and Prizes | 2 | 2024 | 71 | 0.080 |
Why?
| | Gene Silencing | 1 | 2011 | 202 | 0.080 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 61 | 0.080 |
Why?
| | Aged | 8 | 2026 | 26217 | 0.080 |
Why?
| | Transcriptome | 1 | 2017 | 1042 | 0.080 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 117 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2240 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1777 | 0.080 |
Why?
| | Disease | 1 | 2010 | 96 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2131 | 0.080 |
Why?
| | Ultrasonography, Interventional | 1 | 2011 | 166 | 0.070 |
Why?
| | Wnt Signaling Pathway | 1 | 2011 | 212 | 0.070 |
Why?
| | United States | 5 | 2026 | 16126 | 0.070 |
Why?
| | Phosphorylation | 1 | 2013 | 1708 | 0.070 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2009 | 112 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 132 | 0.070 |
Why?
| | Drug Design | 1 | 2009 | 175 | 0.070 |
Why?
| | DNA, Helminth | 1 | 2008 | 26 | 0.070 |
Why?
| | Metabolomics | 1 | 2014 | 733 | 0.070 |
Why?
| | Models, Chemical | 1 | 2009 | 250 | 0.070 |
Why?
| | Osteoporosis | 1 | 2010 | 239 | 0.070 |
Why?
| | Pheromones | 1 | 2007 | 22 | 0.070 |
Why?
| | Chemoreceptor Cells | 1 | 2007 | 50 | 0.060 |
Why?
| | Incidence | 2 | 2026 | 2934 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2008 | 538 | 0.060 |
Why?
| | DNA Primers | 1 | 2008 | 505 | 0.060 |
Why?
| | Genotype | 1 | 2011 | 1857 | 0.060 |
Why?
| | Databases, Factual | 2 | 2024 | 1491 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2026 | 6085 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2006 | 387 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1450 | 0.060 |
Why?
| | Kidney | 2 | 2011 | 1497 | 0.060 |
Why?
| | Cohort Studies | 3 | 2022 | 6033 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1043 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2008 | 588 | 0.050 |
Why?
| | Research Support as Topic | 1 | 2024 | 81 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 855 | 0.050 |
Why?
| | Seasons | 1 | 2026 | 538 | 0.050 |
Why?
| | Adult | 5 | 2026 | 40881 | 0.050 |
Why?
| | Education, Graduate | 1 | 2023 | 35 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 615 | 0.050 |
Why?
| | Death, Sudden | 1 | 2023 | 26 | 0.050 |
Why?
| | Transfection | 2 | 2022 | 927 | 0.050 |
Why?
| | Peptides | 1 | 2009 | 999 | 0.050 |
Why?
| | Angina Pectoris | 1 | 2023 | 76 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2024 | 17330 | 0.050 |
Why?
| | Cell Membrane | 1 | 2006 | 709 | 0.050 |
Why?
| | DNA | 1 | 2009 | 1437 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3634 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1247 | 0.040 |
Why?
| | Disease Progression | 1 | 2009 | 2865 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 474 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2020 | 8347 | 0.040 |
Why?
| | Glucosides | 1 | 2020 | 56 | 0.040 |
Why?
| | Organelles | 1 | 2020 | 55 | 0.040 |
Why?
| | Nobel Prize | 1 | 2020 | 6 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2020 | 362 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 779 | 0.040 |
Why?
| | Drug-Eluting Stents | 1 | 2020 | 88 | 0.040 |
Why?
| | Prevalence | 1 | 2026 | 2875 | 0.040 |
Why?
| | Proteome | 1 | 2004 | 513 | 0.040 |
Why?
| | Charities | 1 | 2018 | 12 | 0.040 |
Why?
| | Foundations | 1 | 2018 | 27 | 0.040 |
Why?
| | Training Support | 1 | 2018 | 35 | 0.040 |
Why?
| | Inflammation | 2 | 2022 | 2884 | 0.030 |
Why?
| | Risk Factors | 2 | 2024 | 10919 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 354 | 0.030 |
Why?
| | Prospective Studies | 2 | 2022 | 8078 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 11794 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 297 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2601 | 0.030 |
Why?
| | Nicotinic Agonists | 1 | 2018 | 135 | 0.030 |
Why?
| | Risk | 1 | 2019 | 923 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1330 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2018 | 423 | 0.030 |
Why?
| | Nicotine | 1 | 2018 | 331 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2110 | 0.030 |
Why?
| | Angina Pectoris, Variant | 1 | 2014 | 3 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2026 | 5925 | 0.030 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2020 | 549 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1662 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2014 | 125 | 0.020 |
Why?
| | Students, Medical | 1 | 2018 | 378 | 0.020 |
Why?
| | Age Factors | 1 | 2021 | 3346 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 166 | 0.020 |
Why?
| | Organ Specificity | 1 | 2014 | 309 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7134 | 0.020 |
Why?
| | Mice | 1 | 2010 | 18356 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5428 | 0.020 |
Why?
| | Smoking | 1 | 2018 | 1477 | 0.020 |
Why?
| | Angioplasty, Balloon | 1 | 2011 | 94 | 0.020 |
Why?
| | Cosmids | 1 | 2004 | 8 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 59 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14254 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2004 | 130 | 0.010 |
Why?
| | Child | 1 | 2022 | 22740 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 638 | 0.010 |
Why?
| | Cell Line | 1 | 2004 | 2823 | 0.010 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|